SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 31, 2001
-----------------------------------
NEOGEN CORPORATION
-----------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Michigan 0-17988 38-2367843
---------------------------- ----------------------- -------------------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
620 Lesher Place, Lansing, Michigan 48912
-----------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (517) 372-9200
-----------------------------------
----------------------------------------------------------------
(Former name or former address, if changed since last report.)
1
ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS
As of July 31, 2001, Neogen Corporation acquired substantially all of the
operating assets of Gene-Trak Systems, a wholly owned subsidiary of Vysis, Inc.
(Nasdaq: VYSI).
Gene-Trak Systems is a Massachusetts-based supplier of foodborne pathogen
detection products based on DNA probe technology. Gene-Trak's revenues were
approximately $3 million in its most recently completed fiscal year. There is no
relationship between Neogen and Vysis or any of its affiliates.
The consideration for the sale, which was determined through arms length
negotiations, was $3.5 million. The source of cash consideration was available
Neogen cash balances.
Neogen plans to continue operations at Gene-Trak's Hopkinton, Massachusetts,
leased facility in the near future, with longer term plans of totally
integrating Gene-Trak operations into Neogen's Lansing, Michigan facilities.
ITEM 7. FINANCIAL STATEMENTS, PROFORMA INFORMATION AND EXHIBITS
(a) Financial Statements Of Business To Be Acquired
(b) Proforma Financial Information
Financial statements and proforma financial information of the business acquired
are not required by the applicable rules and regulations of the Securities and
Exchange Commission as the acquisition is not considered to be significant.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Neogen Corporation
(Registrant)
Date: August 14, 2001 By: /s/ Richard R. Current
------------------------------------------
Richard R. Current
Vice President and Chief Financial Officer
2